TRT labs before starting testosterone replacement therapy require a minimum of seven essential blood tests to establish baseline hormone levels and screen for contraindications. These include total testosterone (measured twice, ideally between 7-10 AM), free testosterone, luteinizing hormone (LH), follicle-stimulating hormone (FSH), complete blood count (CBC), comprehensive metabolic panel (CMP), and lipid profile. The Endocrine Society recommends two morning testosterone measurements below 300 ng/dL for diagnosis. Additional tests may include prostate-specific antigen (PSA) for men over 40, estradiol, thyroid-stimulating hormone (TSH), and vitamin D levels. These baseline measurements help your physician determine if you qualify for testosterone therapy and establish reference points for monitoring treatment effectiveness and safety throughout 2026 and beyond.
Key Takeaways
- Two morning testosterone measurements below 300 ng/dL are required for TRT qualification
- Seven essential lab tests establish baseline hormone levels and screen for safety concerns
- PSA testing is mandatory for men over 40 before starting testosterone therapy
- Complete blood count and metabolic panel identify potential contraindications
- Follow-up lab monitoring occurs at 3-6 month intervals during treatment
Core Hormone Panel Requirements
Total testosterone forms the cornerstone of TRT lab testing, with the Endocrine Society requiring two separate measurements taken between 7-10 AM when testosterone levels peak naturally. Your physician needs values consistently below 300 ng/dL, though some practitioners consider treatment for symptomatic men with levels below 400 ng/dL. Free testosterone provides additional insight since only 1-3% of circulating testosterone remains unbound and biologically active. LH and FSH measurements distinguish between primary and secondary hypogonadism. Primary hypogonadism shows elevated LH and FSH with low testosterone, while secondary hypogonadism presents with low or normal LH/FSH alongside low testosterone. This distinction affects treatment approach and monitoring protocols. Estradiol levels help identify aromatase activity, which becomes important for managing side effects during treatment.Safety Screening Laboratory Tests
CBC testing identifies baseline red blood cell counts, hemoglobin, and hematocrit levels before testosterone therapy begins. Testosterone increases red blood cell production through enhanced erythropoietin, with studies showing hematocrit increases of 3-5% during the first year of treatment. Baseline values above 50% may disqualify candidates due to increased thrombotic risk. Your comprehensive metabolic panel evaluates kidney function, liver enzymes, and electrolyte balance. Testosterone therapy can affect lipid metabolism and liver function, particularly with oral formulations. PSA testing remains mandatory for men over 40, as testosterone may accelerate existing prostate cancer growth. Normal PSA values below 4.0 ng/mL are generally required, though age-adjusted reference ranges apply for older men.Additional Diagnostic Considerations
Thyroid function testing through TSH measurement helps identify concurrent endocrine disorders that mimic or contribute to hypogonadism symptoms. Hypothyroidism affects approximately 15% of men seeking testosterone therapy and requires treatment before starting TRT. Vitamin D deficiency correlates with low testosterone in observational studies, making 25-hydroxy vitamin D testing valuable for optimization. Insulin resistance assessment through fasting glucose and hemoglobin A1C identifies metabolic syndrome, which affects testosterone production and treatment response. Men with diabetes require more frequent monitoring due to testosterone's effects on glucose metabolism. Some practitioners include inflammatory markers like C-reactive protein, as chronic inflammation suppresses testosterone production and may benefit from concurrent peptide therapy approaches.Monitoring and Follow-up Testing
Follow-up laboratory monitoring occurs at 3 months after starting TRT, then every 6 months once levels stabilize. Total testosterone targets range from 400-700 ng/dL for most men, though individual symptoms guide dosing adjustments. Hematocrit monitoring remains critical, with values above 52% requiring dose reduction or therapeutic phlebotomy. PSA monitoring continues every 6-12 months, with increases above 1.4 ng/mL in one year or 0.4 ng/mL in six months warranting urological evaluation. Liver function tests repeat annually for injectable testosterone or every 6 months for oral formulations. Some patients pursuing Sermorelin guide protocols may require growth hormone and IGF-1 monitoring alongside standard TRT labs.Frequently Asked Questions
How long should I fast before TRT labs?
Fasting for 8-12 hours is required for lipid panel and glucose testing, but testosterone levels don't require fasting. Schedule your blood draw between 7-10 AM when testosterone peaks naturally. Avoid intense exercise, alcohol, and stress for 24 hours before testing, as these factors can artificially lower testosterone measurements.
Check if TRT is right for you
Take a free 2-minute assessment to see if testosterone replacement therapy could help restore your energy, mood, and vitality.
Start Free Assessment →View data table
| Category | Patients Reporting Improvement (%) | Detail |
|---|---|---|
| Energy | 78 | Improves in 2-4 weeks |
| Mood | 72 | Stabilizes in 4-6 weeks |
| Libido | 82 | Returns in 3-6 weeks |
| Muscle | 65 | Visible at 3-4 months |
| Body Fat | 58 | Reduces over 6+ months |
Can I take supplements before my TRT labs?
Stop all testosterone boosters, DHEA, and hormone-affecting supplements 2-4 weeks before testing to get accurate baseline readings. Vitamin D and basic multivitamins are generally acceptable, but inform your physician about all supplements. Some herbal products like ashwagandha or tongkat ali may artificially elevate testosterone levels.
Why do I need two testosterone tests?
Testosterone levels fluctuate daily due to stress, sleep, illness, and circadian rhythms. The Endocrine Society requires two separate low readings to confirm hypogonadism and avoid treating temporary suppression. Single low readings may reflect acute illness, poor sleep, or laboratory error rather than true testosterone deficiency requiring treatment.
What testosterone level qualifies for TRT?
Most guidelines require total testosterone below 300 ng/dL on two separate morning measurements. However, symptomatic men with levels between 300-400 ng/dL may qualify if they have low free testosterone, multiple symptoms, and no other underlying causes. Individual symptoms matter more than absolute numbers for treatment decisions.
How much do pre-TRT labs cost in 2026?
Complete pre-TRT lab panels range from $200-500 without insurance, depending on your location and laboratory. Many insurance plans cover diagnostic hormone testing when ordered by a physician for symptoms. Direct-pay laboratory services often offer hormone panels for $150-300, though interpretation by a qualified physician remains essential for treatment decisions.
Sources
- Bhasin S, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. PMID: 29562364
- Mulhall JP, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. PMID: 29601923
- Corona G, et al. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytical study. Eur J Endocrinol. 2011;165(5):687-701. PMID: 21852391
- Shores MM, et al. Low serum testosterone and mortality in male veterans. Arch Intern Med. 2006;166(15):1660-1665. PMID: 16908801
- Basaria S, et al. Adverse events associated with testosterone administration. N Engl J Med. 2010;363(2):109-122. PMID: 20592293
- Saad F, et al. A safety review of testosterone replacement therapy for men. Expert Opin Drug Saf. 2011;10(2):187-205. PMID: 21235428
- Morgentaler A, et al. Fundamental concepts regarding testosterone deficiency and treatment: international expert consensus resolutions. Mayo Clin Proc. 2016;91(7):881-896. PMID: 27313122